Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,803 total articles
Becton, Dickinson (BDX) looks comfortably priced against its cash flow and dividend pedigree, but the market is still demanding proof of a durable earnings re-acceleration. This trade plan buys into recurring consumables revenue and FCF strength while protecting capital with a tight stop and a near-term target tied to mean reversion toward prior re…
Sify Technologies has the market structure and recent operational momentum that make it an attractive swing trade ahead of a potential IPO of its data-center subsidiary. Market cap sits under $1.0B, management is expanding capacity in key metros, and demand from hyperscalers remains robust. Take a tactical long with a clear stop and a mid-term targ…
Marvell is uniquely positioned at the intersection of high-bandwidth optics and custom AI networking silicon. With improving cash flow, healthy margins, strategic hyperscaler partnerships and a recent catalytic investment from Nvidia, the stock looks set to reprice higher as AI datacenter rollouts accelerate. This trade idea lays out a clear entry …
Taiwan Semiconductor (TSM) is the primary beneficiary of the next wave of AI silicon demand. With record earnings tied to AI chips, dominant foundry share and improving technicals, TSM offers an asymmetric risk-reward for a 180-trading-day position. Entry at $365, stop at $345, target $420.
Oracle has been the market's favorite way to play AI infrastructure recently, driven by partnerships and energy solutions that address data-center constraints. A confirmed strategic deal with a hyperscaler like AWS would likely accelerate revenue and margin re-rating; a disappointment or smaller-than-expected deal risks a sharp pullback after a vio…
Alphabet is trading near $342 after an intense move higher. The company combines durable cash generation from ads with accelerating Google Cloud revenue and optionality from stakes in Waymo and SpaceX. This trade idea lays out an actionable long with precise entry, stop, and target for a long-term (180 trading days) horizon.
Millicom (TIGO) is positioned for a multi-quarter rerate following consolidation in Colombia and targeted South American expansion. The stock trades at a reasonable multiple with a 3.7% yield, management is proposing buybacks and a $3/share dividend, and recent purchases (UNE/Coltel/Ecuador) create a clearer growth runway. This trade targets a re-r…
lululemon is trading at an attractive set of multiples (PE ~12, EV/EBITDA ~6.5) despite solid profitability (ROE ~31%, FCF ~$922M). Technicals show bullish momentum and short interest has fallen; with catalysts like international expansion and a resilient DTC model, the stock looks set to re-rate. Trade plan: enter $168.00, stop $150.00, target $23…
Petrobras still screens cheap on headline multiples and yields, but near-term Iran tensions raise volatility and compress the margin for error. A disciplined, mid-term long with a tight stop and clear targets balances upside from cash flow and dividends against geopolitical and governance risks.
MPLX LP is a midstream operator with stable, volume-based cash flows, a 7%+ yield and multi-year growth projects that support mid-single-digit distribution growth. Recent geopolitical-driven oil volatility has created noise but not a change to the underlying fundamentals. For traders willing to hold through headline risk, a directional long with a …
Advanced Micro Devices is trading near an all-time high but retains an asymmetric upside if it converts AI GPU and server CPU momentum into sustained data-center revenue and margin expansion. This trade outlines a clear entry at $280, a stop at $230, and a $600 target over a long-term (180 trading days) horizon, with catalysts, valuation context, a…
RF Industries is trading near its 52-week high after a string of quarters showing revenue growth, a 450 bp gross margin improvement, and a $19.7M backlog. Balance sheet metrics (EV ~$152.5M, free cash flow ~$4.39M) and rising technical momentum justify a mid-term swing trade. Entry $14.00, target $18.00, stop $11.00; horizon: mid term (45 trading d…
Tenaz Energy (ticker: TENZ) behaves like an equity call on European natural gas. With limited public detail available, this trade is driven by macro supply risks and recent market flow that can re-rate exposed small-cap energy names. Enter at $4.50, stop $3.20, target $9.00. Risk is high; position size should be limited to a small portion of risk c…
MercadoLibre combines high-margin fintech revenue with continued e-commerce expansion across underpenetrated Latin American markets. With 45%+ revenue growth, $83.7B payment volume and expanding credit sales, the stock's earnings profile supports a mid-term long trade after the recent pullback. This plan targets $2,300 with a $1,700 stop over a 45 …
Kemper's 5.875% fixed-rate reset junior subordinated debentures (KMPB) trade below par at $23.90 and offer a current cash yield near 6.7% plus a path to par if interest rates and credit sentiment improve. The issuer's solid free cash flow and modest leverage leave room for stabilization; this trade targets mean reversion to $25 with a favorable ris…
Main Street Capital (MAIN) has had a bumpy start to 2026 but the core credit franchise looks intact: strong ROE, low non-accruals reported in recent results, and a durable monthly payout. The shares trade at roughly 10x earnings and 1.65x book with a market cap near $4.94B. This trade targets a recovery to prior highs while locking in an attractive…
TTD has been punished for agency disputes and executive churn, but financials and technicals are now signaling a tradable bottom. This actionable upgrade targets a defined swing trade with clear risk management while acknowledging the headline risks that can keep the stock volatile.
GSK offers a compelling risk/reward: a $119B market-cap diversified pharma with steady cash flow, a 2.7% dividend yield, reasonable P/E of 15.7, and meaningful upside if its oncology expansion (Mo-Rez program) shows clinical progress. Technicals support continuation higher and near-term risk is contained with a clear stop. This trade is a long-term…
Autoliv (ALV) combines steady free cash flow, a healthy dividend, visible buyback capacity and a reasonable multiple. Current pullback offers a defined-risk entry to capture a re-rate toward prior highs and to monetize buyback-driven EPS upside over the next 6-8 weeks.
British American Tobacco (BTI) offers a 5.4%+ yield, low-teens P/E and a market cap of roughly $123B. Its cash generation and durable pricing power underpin a defensive, income-first position for me. This trade lays out an entry at $56.675, a stop at $50.00 and a target of $68.00 over a long-term horizon (180 trading days), with clear catalysts and…
Onto Innovation (ONTO) has more than doubled over the last four years, but its $14.5B market cap, $300M+ free cash flow, and net-cash balance sheet make a risk-adjusted long trade attractive. This piece lays out a concrete entry, stop and target plan across time horizons and explains why fundamentals and near-term catalysts support further upside w…
Sezzle looks like a tradeable long after a phase of operational fixes and cost discipline. With early signs of GMV re-acceleration, improved merchant economics, and a cheaper public multiple versus prior cycles, a measured swing-position can capture upside while keeping downside limited with a clear stop. This piece lays out the thesis, catalysts, …
MercadoLibre has effectively traded sideways in market impact terms over the last five years despite sustained double-digit top-line growth. Fundamentals are strong - 40%+ revenue growth, $10.8B free cash flow and 78M monthly active users - but heavy reinvestment and AI spending have compressed near-term margins and the multiple. With FCF yield nor…
TG Therapeutics has converted regulatory wins into meaningful revenue growth for BRIUMVI, raised guidance, and — with the addition of $500 million of non-dilutive capital — materially de-risks near-term funding. The combination of fundamental momentum and constructive technicals supports a swing-long idea with a clear entry, stop and target.
Nano Labs (NA) is a small-cap fabless semiconductor outfit that pivoted aggressively into crypto reserves and Web3 infrastructure in 2025. The stock is trading at a steep discount to historical levels and to replacement-cost logic, while management has signaled conviction via a large insider purchase. We upgrade to Buy and present a mid-term trade …
